pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
BRISTOL MYERS SQUIBB · news · pharmadog
← back to BRISTOL MYERS SQUIBB
News mentioning BRISTOL MYERS SQUIBB
305
stories
7h
Bristol Myers defends pipeline, reinforces later-stage BD interest
endpoints
10h
BMS drops Prothena-partnered neuro drug, sales outlook improves on a Q3 beat
biospace
12h
LENZ cuts 75% of staff as third quarter earnings disappoint
biospace
17h
BMS walks away from $80M neurodegeneration bet after phase 1
fiercebiotech
1d
Data leak kickstarts ESMO, BMS reports autoimmune CAR T death, pharma M&A outpaces 2025
biospace
1d
Astellas makes $1.3B bet on Audax’s preclinical push to reverse decades of IL-12 woes
fiercebiotech
1d
Big Pharma is ready to strike, with J&J most likely to buy: Leerink
biospace
1d
5 new drug launches that defied industry expectations
biospace
2d
Artiva to quit autoimmune cell therapy work, cut staff after patient deaths
biopharma dive
2d
Artiva lays off 94% of staff after deaths and durability sink autoimmune cell therapy
fiercebiotech
2d
From RAS rivalries to leaked cancer vaccine readouts, ESMO brought the data drama
fiercebiotech
3d
STAT+: Roche gets a lung cancer win with its KRAS drug divarasib
stat
3d
ESMO ‘26: A cancer vaccine debate, Roche’s KRAS progress and Amgen’s ‘unprecedented’ data
biopharma dive
3d
ESMO 2026: Analysts warm to Merck, Moderna’s cancer vaccine after frustrating data leak
biospace
3d
Another autoimmune CAR-T death; Treasury zeroes in on China deals
biopharma dive
3d
STAT+: Incyte pancreatic cancer medicine induces lasting tumor responses, company says at ESMO
stat
3d
STAT+: Five biotech updates to read after ESMO this weekend
stat
3d
STAT+: Pharmalittle: We’re reading about a Roche lung cancer drug, a Bristol CAR-T trial death, and more
stat
3d
BMS joins 3-year partnership to boost participation in cancer trials
fiercebiotech
3d
Anthropic lays out drug R&D ambitions, risks in mammoth IPO filing
fiercebiotech
3d
STAT+: Moderna CEO on what’s next after success in cancer vaccine
stat
4d
#ESMO26: Roche details magnitude of its KRAS G12C inhibitor’s win over rivals in lung cancer trial
endpoints
4d
ESMO: BMS’ Massacesi hails ‘very promising’ data for BioNTech-partnered PD-L1xVEGF-A drug
fiercebiotech
4d
#ESMO26: Pfizer looks beyond lung cancer flop as BioNTech, Bristol Myers show early activity
endpoints
5d
STAT+: The ESMO presentation everyone’s been waiting for
stat
5d
ESMO: Roche touts ‘convincing’ phase 3 KRAS data after win over rivals
fiercebiotech
6d
STAT+: Highly anticipated Moderna-Merck melanoma cancer vaccine data arrived early
stat
6d
STAT+: Diabetes association says ‘threat’ preceded members’ ejections, but admits policies were unclear
stat
6d
STAT+: Patient dies in Bristol Myers Squibb autoimmune CAR-T trial
stat
6d
Q&A: Bristol Myers' Lynelle Hoch on autoimmune CAR-T safety challenges
endpoints
← prev
page 1 of 11
next →
